![Michael Wheatcroft](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Wheatcroft
Directeur Technique/Scientifique/R&D chez TELIX PHARMACEUTICALS LIMITED
Profil
Michael Wheatcroft is currently the Chief Scientist at Telix Pharmaceuticals Ltd.
He previously worked as a Principal at Medimmune UK Ltd.
and as a Research Manager at Avipep Pty Ltd.
He holds a doctorate degree from the University of Cambridge.
Postes actifs de Michael Wheatcroft
Sociétés | Poste | Début |
---|---|---|
TELIX PHARMACEUTICALS LIMITED | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Michael Wheatcroft
Sociétés | Poste | Fin |
---|---|---|
Medimmune UK Ltd.
![]() Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Corporate Officer/Principal | - |
Avipep Pty Ltd.
![]() Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Corporate Officer/Principal | - |
Formation de Michael Wheatcroft
University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TELIX PHARMACEUTICALS LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Avipep Pty Ltd.
![]() Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Health Technology |
Medimmune UK Ltd.
![]() Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Process Industries |